BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24825391)

  • 1. Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Kim JH; Doo SW; Yang WJ; Lee KW; Lee CH; Song YS; Jeon YS; Kim ME; Kwon SS
    Int J Urol; 2014 Oct; 21(10):987-90. PubMed ID: 24825391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.
    Oh JJ; Jeong SJ; Lee BK; Jeong CW; Byun SS; Hong SK; Lee SE
    BJU Int; 2013 Aug; 112(4):E265-71. PubMed ID: 23432960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.
    Bañez LL; Albisinni S; Freedland SJ; Tubaro A; De Nunzio C
    World J Urol; 2014 Apr; 32(2):323-8. PubMed ID: 22847453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE Study.
    Vidal AC; Howard LE; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    J Urol; 2015 Jul; 194(1):52-7. PubMed ID: 25661298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.
    Ng CF; Chiu PK; Lam NY; Lam HC; Lee KW; Hou SS
    Int Urol Nephrol; 2014 Apr; 46(4):711-7. PubMed ID: 24136184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
    Park J; Cho SY; Lee SB; Son H; Jeong H
    BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population.
    Wallner LP; Frencher SK; Hsu JW; Chao CR; Nichol MB; Loo RK; Jacobsen SJ
    BJU Int; 2013 Jun; 111(8):1245-52. PubMed ID: 23320750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for serum human tissue kallikrein in detection of prostate cancer?
    Ochiai A; Shukla A; Davis JW; Fritsche HA; Bhadkamkar V; Babaian RJ
    Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy.
    Chevli KK; Duff M; Walter P; Yu C; Capuder B; Elshafei A; Malczewski S; Kattan MW; Jones JS
    J Urol; 2014 Jun; 191(6):1743-8. PubMed ID: 24333241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of percent free prostate-specific antigen in repeat prostate biopsy.
    Lee BH; Hernandez AV; Zaytoun O; Berglund RK; Gong MC; Jones JS
    Urology; 2011 Aug; 78(2):386-91. PubMed ID: 21683989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
    Javali TD; Dwivedi DK; Kumar R; Jagannathan NR; Thulkar S; Dinda AK
    Int J Urol; 2014 Mar; 21(3):257-62. PubMed ID: 23980749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis.
    Gorday W; Sadrzadeh H; de Koning L; Naugler CT
    Clin Biochem; 2015 Dec; 48(18):1230-4. PubMed ID: 26164541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
    Jue JS; Barboza MP; Prakash NS; Venkatramani V; Sinha VR; Pavan N; Nahar B; Kanabur P; Ahdoot M; Dong Y; Satyanarayana R; Parekh DJ; Punnen S
    Urology; 2017 Jul; 105():123-128. PubMed ID: 28431993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml.
    Li YH; Elshafei A; Li J; Gong M; Susan L; Fareed K; Jones JS
    Eur Urol; 2014 Jun; 65(6):1178-83. PubMed ID: 23768632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.